W D Tilley

Prostate cancer in a transgenic mouse.

R. Matusik, W. Tilley, D. Medina, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor.

R A Irvine, G. Coetzee, S. S. Koh, 2000, Cancer research.

Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer.

D. Horsfall, V. Marshall, W. Tilley, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer.

D. Horsfall, R. Sutherland, P. Stricker, 1999, Cancer research.